Delivery Order SPE2DB24D2101-SPE2DB24FKFTT

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to supply the U.S. Department of Defense with varenicline 0.5 mg tablets. The contract has a ceiling value of $2,522.62 and a period of performance through March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract valued at $1,673.82 for the supply of 4,565,031,699 units of the drug varenicline 1 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a wide range of pharmaceutical...
This is a $3,880.42 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 56-count packages of the prescription drug varenicline 1 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
This is a $4,218.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 56 tablets of the drug Varenicline 1 mg. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,958.30 delivery order contract is for the supply of 4,567,926,810 tablets of the drug Varenicline 0.5 mg, a medication used to treat nicotine addiction. The contract has a firm fixed price and an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a $2,660.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,178,712 units of the prescription medication varenicline 1 mg tablet, with a completion date of May 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,078.92 to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of 56 tablets of the medication Varenicline 1 mg. The contract has a period of performance through March 11, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order contract. The company also...
This is a $1,016.50 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Varenicline 1 mg tablets, a prescription medication. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,239,290 units of the medication varenicline 1 mg tablets in 56-count packages. The contract has a ceiling value of $1,840.24 and a period of performance through May 15, 2025. The contract is a firm-fixed price, non-set-aside delivery order, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.94 firm fixed-price delivery order is for the supply of 56 tablets of the medication Varenicline 0.5 mg. The award has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFTT
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $15,441.11 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 56-count packs of the drug Varenicline 1 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by August 9, 2024.

Generated 11/7/24, 9:42 AM